Jane Street Group, LLC Mesoblast LTD Call Options Transaction History

Jane Street Group, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 17, 2021	SELL	$8.21 - $18.59 $1.63 Million - $3.68 Million	-198,200 Reduced 87.24%	29,000 $251,000
Q3 2020 Nov 17, 2020	BUY	$11.33 - $19.81 $2.23 Million - $3.89 Million	196,600 Added 642.48%	227,200 $4.13 Million
Q2 2020 Aug 17, 2020	BUY	$4.2 - $15.45 $128,520 - $472,770	30,600 New	30,600 $343,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.